Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Esperion Therapeutics, Inc. - Common Stock
(NQ:
ESPR
)
4.004
+0.204 (+5.37%)
Streaming Delayed Price
Updated: 3:23 PM EST, Dec 19, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Esperion Therapeutics, Inc. - Common Stock
< Previous
1
2
...
7
8
9
10
11
12
13
14
Next >
28 Stocks Moving in Wednesday's Pre-Market Session
↗
November 24, 2021
Gainers Engine Gaming and Media, Inc. (NASDAQ: GAME) rose 51% to $4.80 in pre-market trading after the company reported Q4 2021 and FY21 revenue was higher year over year....
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
↗
November 24, 2021
We're starting the last day of this short holiday week with a dive into the biggest pre-market stock movers for Wednesday!
Via
InvestorPlace
12 Health Care Stocks Moving In Tuesday's After-Market Session
↗
November 23, 2021
Gainers Biolase (NASDAQ:BIOL) shares incr...
Via
Benzinga
56 Biggest Movers From Yesterday
↗
November 24, 2021
Gainers Aptevo Therapeutics Inc. (NASDAQ: APVO) shares jumped 162.8% to close at $17.03 after the company announced a clinical update for its Phase 1b Expansion trial evaluating...
Via
Benzinga
Thursday Market Overview
↗
November 04, 2021
If you are an IBM shareholder you now own something new Kyndryl.
Via
Talk Markets
Esperion Therapeutics, inc (ESPR) Q3 2021 Earnings Call Transcript
↗
November 02, 2021
ESPR earnings call for the period ending September 30, 2021.
Via
The Motley Fool
Topics
Earnings
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
↗
November 02, 2021
Gainers Bone Biologics (NASDAQ:BBLG) shares rose 33.57% to $7.32 during Tuesday's pre-market session. The company's market cap stands at $224.5 million. Artelo...
Via
Benzinga
The Daily Biotech Pulse: Pfizer Reports Solid Q3 Earnings, Regulatory Setback For Legend, Lilly to Supply Additional COVID-19 Antibody Cocktails To US
↗
November 02, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus SAB Spikes On Analyst Action SAB Biotherapeutics, Inc. (NASDAQ: SABS) shares...
Via
Benzinga
The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline
↗
October 31, 2021
Biotech stocks rose a third week running in the week ending Oct. 29 amid positive reaction to earnings. Big pharma earnings were mostly better than expected. Merck & Co, Inc...
Via
Benzinga
56 Biggest Movers From Yesterday
↗
October 26, 2021
Gainers Bakkt Holdings, Inc. (NYSE: BKKT) shares jumped 234.4% to close at $30.60 on Monday after the company and Mastercard announced a partnership for crypto and loyalty...
Via
Benzinga
Why Esperion Therapeutics Plummeted by 11% Today
↗
October 25, 2021
Shareholders were displeased with the company's latest financial move.
Via
The Motley Fool
12 Health Care Stocks Moving In Monday's Intraday Session
↗
October 25, 2021
Gainers Jaguar Health (NASDAQ:JAGX) shares increased by 14.64% to $2.08 during Monday's regular session. The current volume of 7.2 million shares is 300.39% of Jaguar...
Via
Benzinga
35 Stocks Moving In Monday's Mid-Day Session
↗
October 25, 2021
Gainers Greenpro Capital Corp. (NASDAQ: GRNQ) shares jumped 122% to $1.8895 after the company announced its incubated company Angkasa-X has successfully admitted as an ITU-R...
Via
Benzinga
Bitcoin Futures Arrive
↗
October 19, 2021
Today you can finally hold Bitcoins via an exchange-traded fund.
Via
Talk Markets
Esperion Chops 40% Workforce As Launch Of Cholesterol Medication Falters
↗
October 18, 2021
Esperion Therapeutics Inc's (NASDAQ: ESPR) cholesterol drug marketing strategy has soured badly, as it has been struggling to sell its heart disease pill for more than a...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 19, 2021
↗
October 19, 2021
Upgrades Maxim Group upgraded the previous rating for Indaptus Therapeutics Inc (NASDAQ:
Via
Benzinga
44 Biggest Movers From Yesterday
↗
October 15, 2021
Gainers Benessere Capital Acquisition Corp. (NASDAQ: BENER) shares jumped 66.5% to close at $0.4530 on Thursday. Grove, Inc. (NASDAQ: GRVI) gained 39.3% to close at $6.98 after...
Via
Benzinga
More Chinese Trouble
↗
October 14, 2021
A day after the consumer price rise there was another price rise for producer markets.
Via
Talk Markets
Benzinga's Top Ratings Upgrades, Downgrades For October 14, 2021
↗
October 14, 2021
Upgrades According to Roth Capital, the prior rating for Ring Energy Inc (AMEX:
Via
Benzinga
The Daily Biotech Pulse: Allogene Sinks On FDA Clinical Hold, Takeda Gets Adcom Backing, Quidel Reports Q3 COVID Revenues, IPOs
↗
October 08, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 7) Alkermes plc (NASDAQ: ALKS)...
Via
Benzinga
The Daily Biotech Pulse: Moderna Invests In Africa, Amgen Announces Neuroscience R&D Collaboration, Decision Day For Chemocentryx, Biophytis To Restate Results
↗
October 07, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 6) Enanta Pharmaceuticals, Inc...
Via
Benzinga
The Daily Biotech Pulse: Takeda Suspends Studies On Safety Scare, Acer's Sleep Disorder Drug Filing Accepted For Review, Voyager's Licensing Options Deal
↗
October 06, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 5) Bicycle Therapeutics plc (...
Via
Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
↗
September 24, 2021
Gainers eFFECTOR Therapeutics (NASDAQ:
Via
Benzinga
The Daily Biotech Pulse: Lilly, Regeneron Ink COVID-19 Drug Deal With US, Regulatory Setback For Calliditas, Theravance To Cut 75% Jobs, 4 IPOs
↗
September 15, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 14) Alcon Inc. (NYSE: ALC)...
Via
Benzinga
The Daily Biotech Pulse: NRx Rises On COVID-19 Drug Collaboration, Amgen's Lung Cancer Drug Conditionally Approved In Canada, Coherus Data Readout
↗
September 14, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 13) Abbott Laboratories (NYSE...
Via
Benzinga
Most Heavily Shorted Stocks
↗
September 10, 2021
Over the course of 2021, we have seen some aggressive short squeezes, resulting in turmoil for certain financial institutions and millions in profits for some retail traders.
Via
Talk Markets
A Weak Week
↗
September 10, 2021
Chinese car-maker Nio appears to have been able to weather the Beijing crackdown on foreign listed firms better than later entrants.
Via
Talk Markets
The Daily Biotech Pulse: Apellis Sinks On Data, Endo Shines On Opioid Litigation Settlement, T2 Biosystems Soars On Mutant Detection Ability of COVID Test
↗
September 10, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 9) Adagio Therapeutics, Inc. (...
Via
Benzinga
20 Stocks Moving in Friday's Pre-Market Session
↗
September 10, 2021
Gainers IVERIC bio, Inc. (NASDAQ: ISEE) rose 29.6% to $11.26 in pre-market trading. Iveric Bio recently reported inducement grants under Nasdaq Listing Rule 5635(c)(4). T2...
Via
Benzinga
The Daily Biotech Pulse: ProQR-Lilly R&D Partnership, Sanofi's Pemphigus Trial Disappointment, Humanigen's COVID-19 Drug Denied Emergency Use Authorization
↗
September 09, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 8) Abbott Laboratories (NYSE:...
Via
Benzinga
< Previous
1
2
...
7
8
9
10
11
12
13
14
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.